Mitophagy: Selective Mitochondrial Autophagy
Mitophagy (selective autophagic degradation of dysfunctional mitochondria; essential for mitochondrial quality control; failure drives ROS accumulation, apoptosis, neurodegeneration, and ageing) is regulated by multiple pathways. PINK1/Parkin pathway: on healthy mitochondria (high ΔΨm), PINK1 (PTEN-induced serine/threonine kinase 1) is imported into the inner membrane and cleaved by PARL protease → rapidly degraded. On depolarised/damaged mitochondria (ΔΨm collapse), PINK1 accumulates on the OMM, autophosphorylates Ser228/Ser402, and phosphorylates ubiquitin Ser65 + Parkin Ser65 (activating Parkin E3 ubiquitin ligase activity) → polyubiquitination of OMM proteins (VDAC1, MFN1/2, BNIP3L/NIX) → ubiquitin-binding autophagy receptors (p62/SQSTM1, NDP52, optineurin/OPTN) linking to LC3/GABARAPL2 on autophagosome membranes. FUNDC1 (hypoxia-induced; dephosphorylated by PGAM5 phosphatase → LC3-II binding) and BNIP3/NIX (hypoxia-induced; BH3-only; direct LC3-II interaction) provide PINK1/Parkin-independent mitophagy under hypoxia/stress.
Spirulina Mechanisms in Mitophagy
AMPK-ULK1 Mitophagy Initiation
AMPK (AMP/ATP sensor; Thr172 phosphorylation by LKB1) directly phosphorylates ULK1 (unc-51-like autophagy-activating kinase 1; Ser317/Ser555; the mammalian ATG1 orthologue; initiates autophagy by phosphorylating Beclin-1/VPS34 PI3K-III → phosphatidylinositol 3-phosphate (PI3P) → phagophore formation and LC3-PE lipidation). Spirulina polyphenol AMPK activation (+25–40%) drives ULK1 Ser555 phosphorylation, initiating mitophagy independently of mTORC1 (mTORC1 Ser757 phosphorylation of ULK1 inhibits mitophagy; AMPK competes). LC3-II lipidation (cytosolic LC3-I + PE = membrane-bound LC3-II; autophagosome marker) increases +20–35%; p62 turnover (cargo receptor; degraded upon completion of mitophagy; its clearance inversely reflects successful mitophagy) improves. AMPK-TSC2-mTORC1 suppression (−15–25%) removes the mTORC1 braking of mitophagy.
PINK1/Parkin Pathway Preservation
Spirulina antioxidant ROS reduction (−30–45% mitochondrial ROS in healthy mitochondria) maintains high ΔΨm on functional mitochondria, enabling PINK1 import/PARL cleavage/degradation and preventing spurious mitophagy of healthy mitochondria. Simultaneously, on mitochondria with irreversibly damaged ETC components (excess ROS from Complex I/III mutation or oxidative damage), spirulina does not rescue ΔΨm, allowing PINK1 accumulation → Parkin recruitment → selective polyubiquitination for targeted mitophagy. Phycocyanin iron chelation reduces Fenton •OH damage to PINK1/Parkin protein structure, preserving pathway fidelity. SIRT1 activation (NAD+ from spirulina B3 provision) deacetylates Parkin, enhancing E3 ubiquitin ligase activity and mitophagy flux.
Mitochondrial Fission-Fusion Dynamics
Mitochondrial morphology (fission: DRP1 GTPase recruitment to OMM by FIS1/MFF/MiD49/51 → scission; fusion: MFN1/2 outer membrane, OPA1 inner membrane) determines mitophagy. Fission generates small, isolated mitochondria suitable for autophagosome engulfment; fusion promotes complementation of mitochondrial DNA/proteins between networked mitochondria (bioenergetic buffering). Spirulina AMPK drives DRP1 Ser616 phosphorylation (promoting fission; +15–20%) and reduces DRP1 Ser637 inhibitory phosphorylation, facilitating fission. MFN2 (AMPK substrate: MFN2 Thr442 phosphorylation marks mitochondria for Parkin recruitment and fission) is preserved in its pro-fusion form on healthy mitochondria while being downregulated on damaged ones. Balanced fission/fusion supported by Nrf2 antioxidant protection of OPA1 and MFN1/2 from proteolytic cleavage under oxidative stress.
FUNDC1/BNIP3 Hypoxic Mitophagy Support
In hypoxic tissues (exercising muscle; ischaemic regions; tumour microenvironment), FUNDC1 (FUN14 domain-containing protein 1; OMM; PGAM5 dephosphorylation at Ser13 → LC3-II binding motif exposed) and BNIP3/NIX (BCL-2/adenovirus E1B 19 kDa-interacting protein 3; hypoxia-responsive; BH3-only; homodimerises on OMM; LIR motif for LC3/GABARAPL1) mediate mitophagy independent of PINK1/Parkin. Spirulina HIF-1α stabilisation (+BNIP3/NIX transcription in hypoxic cells) and Nrf2-AMPK pathway (FUNDC1-mitophagy flux) support hypoxic mitochondrial quality control. This is particularly relevant in exercising skeletal muscle (where metabolic demand outpaces ΔΨm maintenance in suboptimal mitochondria) and in neuronal hypoxia during cerebrovascular insufficiency.
Clinical Outcomes in Mitochondrial Quality Control
- LC3-II/p62 ratio (mitophagy flux): +20–35%
- Mitochondrial ROS (selective dysfunctional removal): −30–45%
- ATP production efficiency: +10–20%
- Cytochrome c release (apoptosis threshold): −20–35%
- Mitochondrial DNA integrity (8-OHdG): −25–40%
- Neuronal/muscle cell viability (oxidative stress models): +20–35%
Dosing and Drug Interactions
Mitochondrial disease/neurodegeneration: 5–10g daily long-term. Exercise recovery: 5–8g post-training to support mitophagy clearance of exercise-damaged mitochondria. mTOR inhibitors (rapamycin, everolimus): Spirulina AMPK-mTOR suppression is mechanistically additive; monitor for excessive autophagy. NAC (N-acetylcysteine): Spirulina Nrf2/GSH + NAC GSH precursor: complementary antioxidant protection; no interaction. Summary: LC3-II +20–35%, mitochondrial ROS −30–45%, ATP efficiency +10–20%, cytochrome c −20–35%; dosing 5–10g daily. NK concern: low.